The Incidence of Gallstones After Gastrectomy

Sponsor
Hepatopancreatobiliary Surgery Institute of Gansu Province (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05965466
Collaborator
(none)
450
2
2
5.4
225
41.8

Study Details

Study Description

Brief Summary

To provide preventive and therapeutic strategies for participants with gallstones after gastric cancer by comparing the risk of postoperative gallbladder stone formation with two different resection ranges using the Roux-en-Y reconstruction modality in radical gastric cancer surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Distal gastrectomy and radical resection
  • Procedure: Total gastrectomy and radical resection
N/A

Detailed Description

A large number of clinical studies have found that the incidence of gallstones in patients after radical gastric cancer surgery is higher than that in the normal population. However, the pathogenesis has not been clarified, and the prophylactic removal of the gallbladder in patients with gastric cancer remains controversial. A previous study found a statistically significant incidence of gallbladder stones after Billroth I versus Roux-en-Y in distal gastrectomy for gastric cancer. Therefore, the investigators plan to conduct a retrospected cohort study to collect further participants with gastric cancer who underwent total gastrectomy to answer whether different surgical resection ranges during surgery increase the incidence of gallstones this question.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
450 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Distal gastrectomy and Total gastrectomyDistal gastrectomy and Total gastrectomy
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effect of Gastric Cancer Surgical Resection Extent on Postoperative Gallstone Formation: A Retrospected Cohort Study
Anticipated Study Start Date :
Jul 21, 2023
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Distal gastrectomy

Distal subtotal gastrectomy was performed after exclusion of contraindications to surgery. Gastrointestinal reconstruction was performed by residual gastrojejunal Roux-en-Y anastomosis. Anastomosis was performed ex vivo or in vivo.

Procedure: Distal gastrectomy and radical resection
Distal gastrectomy and Roux-en-Y anastomosis

Sham Comparator: Total gastrectomy

Total gastrectomy was performed after the exclusion of contraindications to surgery. Gastrointestinal reconstruction was performed by oesophageal jejunum Roux-en-Y anastomosis. Anastomosis was performed ex vivo or in vivo.

Procedure: Total gastrectomy and radical resection
Total gastrectomy and Roux-en-Y anastomosis

Outcome Measures

Primary Outcome Measures

  1. Number of gallstone patients [5years]

    Two groups of patients with gastric cancer had a follow-up for more than one year and the number of patients with gallbladder stones on B-ultrasound or Computed Tomography (CT)

Secondary Outcome Measures

  1. Number of patients with postoperative complications [5years]

    The number of patients with postoperative complications such as abdominal haemorrhage, fistula, nausea, vomiting, abdominal infection and incision infection in 2 groups of gastric cancer patients

  2. Number of patients with bile duct stones [5years]

    Two groups of patients with gastric cancer had a follow-up for more than one year. Clinical signs such as Charcot's triad and ultrasound, Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) show the number of patients with bile duct stones

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with Gastric Cancer underwent Gastrectomy
Exclusion Criteria:
  • Age less than 18 years or age greater than 75 years;

  • Not Roux-en-Y reconstruction;

  • R0 excision is not achieved;

  • Previous history of upper abdominal surgery, such as cholecystectomy, gastrectomy;

  • History of Endoscopic Submucosal Dissection (ESD) or Endoscopic Mucosal Resection (EMR);

  • Preoperative gallbladder diseases, such as gallstones, gallbladder polyps, chronic cholecystitis;

  • Preoperative neoadjuvant chemotherapy or radiotherapy;

  • Previous history of malignant tumours;

  • Patients with mental or developmental abnormalities or women during pregnancy or breastfeeding;

  • Gastric perforation or bleeding leading to emergency surgery;

  • Palliative surgical treatment;

  • Incomplete case information.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hepatopancreatobiliary Surgery Institute of Gansu Province Lanzhou Gansu China 730000
2 Wuwei Tumor Hospital Wuwei Gansu China 733099

Sponsors and Collaborators

  • Hepatopancreatobiliary Surgery Institute of Gansu Province

Investigators

  • Principal Investigator: Wenbo Meng, M.D., Hepatopancreatobiliary Surgery Institute of Gansu Province

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Wenbo Meng, Director of Surgery, Hepatopancreatobiliary Surgery Institute of Gansu Province
ClinicalTrials.gov Identifier:
NCT05965466
Other Study ID Numbers:
  • GGBS
First Posted:
Jul 28, 2023
Last Update Posted:
Jul 28, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Wenbo Meng, Director of Surgery, Hepatopancreatobiliary Surgery Institute of Gansu Province
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 28, 2023